Lipella pharmaceuticals marks successful first year with strategic progress and key milestones accomplished

–lipella granted two orphan drug designations by fda- pittsburgh, pa, december 20, 2023 – lipella pharmaceuticals inc. (nasdaq: lipo) (“lipella,” “our,” “us” or the “company”) a pioneering, clinical-stage pharmaceutical company, celebrates its first anniversary as a publicly traded entity.
LIPO Ratings Summary
LIPO Quant Ranking